Advertisement

Topics

Cell-therapy startup raises $33.5M from Canaan, Bill Maris’s Section 32 and others

13:07 EDT 16 Apr 2018 | MedCity News

The San Francisco startup has a cloud-based platform to prevent supply chain mistakes in personalized cell and gene therapy where patients’ re-engineered cells need to be delivered back to the correct individual.

Original Article: Cell-therapy startup raises $33.5M from Canaan, Bill Maris’s Section 32 and others

NEXT ARTICLE

More From BioPortfolio on "Cell-therapy startup raises $33.5M from Canaan, Bill Maris’s Section 32 and others"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...